The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Effectiveness of Pentavalent Rotavirus Vaccine in a Large Urban Population in the United States
Abstract
OBJECTIVE: The goal was to assess the effectiveness of complete (3-dose) or partial (1- or 2-dose) immunization with pentavalent rotavirus vaccine (RV5) against rotavirus acute gastroenteritis (AGE) in US clinical practice. METHODS: A case-control evaluation was conducted in February through June 2008 at an emergency department in Houston, Texas. Case patients with rotavirus AGE (N = 90) were identified through testing for rotavirus in fecal specimens obtained from 205 children 15 days through 23 months of age presenting with AGE. Control groups included rotavirus-negative AGE patients (N = 115), concurrently enrolled patients with acute respiratory infection (ARI) (N = 228), and up to 10 age- and zip code-matched children sampled from the Houston-Harris County Immunization Registry (HHCIR) for each case patient >8 months of age. Immunization data were obtained from parent records, health care providers, and/or the HHCIR. Vaccine effectiveness was calculated as 1 minus odds of RV5 vaccination for case patients versus control patients, after adjustment for age at presentation and birth date. RESULTS: The vaccine effectiveness of a complete RV5 series was 89% (95% confidence interval [CI]: 70%–96%) and 85% (95% CI: 55%–95%) with rotavirus-negative AGE and ARI control patients, respectively. Immunization data were available for 44% of case patients (n = 40) from the HHCIR; the estimated 3-dose vaccine effectiveness with these HHCIR control patients was 82% (95% CI: 19%–96%). A complete RV5 series conferred 100% protection (95% CI: 71%–100%) against severe rotavirus disease requiring hospitalization and 96% protection (95% CI: 72%–99%) against disease requiring intravenous hydration. Vaccine effectiveness of 1 and 2 doses against hospitalization and emergency department visits was 69% (95% CI: 13%–89%) and 81% (95% CI: 13%–96%), respectively, using rotavirus-negative AGE and ARI control groups combined. CONCLUSIONS: In this setting, a complete series of RV5 was highly effective against severe rotavirus AGE. Partial immunization also conferred substantial protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
Quality of Primary Care and Subsequent Pediatric Emergency Department Utilization
Brousseau, D. C., Hoffmann, R. G., Nattinger, A. B., Flores, G., Zhang, Y., & Gorelick, M. (2007) · Pediatrics · doi:10.1542/peds.2006-3518 · Cited by 145
Cited by
The case test-negative design for studies of the effectiveness of influenza vaccine
Foppa, I. M., Haber, M., Ferdinands, J. M., & Shay, D. K. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.026 · Cited by 266
do Carmo, G. M. I., Yen, C., Cortes, J., Siqueira, A. A., de Oliveira, W. K., Cortez-Escalante, J. J., Lopman, B., Flannery, B., de Oliveira, L. H., Hage Carmo, E., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001024 · Cited by 260
Self-citationEconomic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
Zhou, F., Shefer, A., Wenger, J., Messonnier, M., Wang, L. Y., Lopez, A., Moore, M., Murphy, T. V., Cortese, M., & Rodewald, L. (2014) · Pediatrics · doi:10.1542/peds.2013-0698 · Cited by 259
Verani, J. R., Baqui, A. H., Broome, C. V., Cherian, T., Cohen, C., Farrar, J. L., Feikin, D. R., Groome, M. J., Hajjeh, R. A., Johnson, H. L., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.037 · Cited by 102
Self-citation
Metadata
- Authors
- Boom, J. A., Tate, J. E., Sahni, L. C., Rench, M. A., Hull, J. J., Gentsch, J. R., Patel, M. M., Baker, C. J., & Parashar, U. D.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2010-02-01
- Volume
- 125
- Issue
- 2
- Pages
- e199-e207
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2150741463
- Cited by
- 200
- References
- 2
- FWCI
- 22.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of Pentavalent Rotavirus Vaccine in a Large Urban Population in the United States. https://app.cochat.ai/papers/10.1542/peds.2009-1021
- The paper
- Boom, J. A., Tate, J. E., Sahni, L. C., Rench, M. A., Hull, J. J., Gentsch, J. R., Patel, M. M., Baker, C. J., & Parashar, U. D. (2010). Effectiveness of Pentavalent Rotavirus Vaccine in a Large Urban Population in the United States. Pediatrics. https://doi.org/10.1542/peds.2009-1021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.